Anzeige
Mehr »
Login
Samstag, 14.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Gold bricht wieder Rekorde: Warum dieser dritte Anstieg anders ist und wie man profitieren kann
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
287 Leser
Artikel bewerten:
(1)

Gastrointestinal Products Market worth $19.7 billion in 2029 driven by Increasing Tech Innovations | MarketsandMarkets

CHICAGO, Aug. 29, 2024 /PRNewswire/ -- The global Gastrointestinal Products Market is valued at an estimated USD 14.7 billion in 2024 and is projected to reach USD 19.7 billion by 2029 at a CAGR of 6.1% during the forecast period. The gastrointestinal products market is driven by the rising prevalence of GI disorders, such as Crohn's disease, ulcerative colitis, IBS, and colorectal cancer, fueled by unhealthy lifestyles, poor diets, and aging populations. Technological advancements, like AI integration, capsule endoscopy, and robotic-assisted devices, are improving diagnostics and treatment. Despite growth opportunities in minimally invasive procedures, stringent regulatory policies hinder product development and innovation. Endoscopy devices, particularly in diagnosing and treating gastrointestinal cancers, dominate the market. North America leads in market share due to high healthcare investments and GI disorder prevalence. Key players include Boston Scientific, Medtronic, Olympus, Fujifilm, and Stryker. Recent innovations include Boston Scientific's single-use bronchoscope and Medtronic's AI-powered GI Genius module.

MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20605595

Browse in-depth TOC on "Gastrointestinal Products Market"
145 - Tables
55 - Figures
350 - Pages

Boston Scientific: Innovator in Gastroenterology Devices

Boston Scientific (U.S.) is a leading player in the gastroenterology market, offering a wide range of innovative products for diagnosing and treating gastrointestinal disorders. Key offerings include the SpyGlass DS Direct Visualization System, designed for enhanced diagnosis and treatment of bile duct and pancreatic diseases, and the EXALT Model D Single-Use Duodenoscope, which reduces infection risks during ERCP procedures. The company also provides therapeutic solutions such as the AXIOS Stent and Electrocautery Enhanced Delivery System and CRE Balloon Dilatation Catheters, improving procedural efficiency and patient outcomes. Through continuous innovation, strategic acquisitions, and a robust global distribution network, Boston Scientific is advancing gastroenterological care worldwide.

Medtronic: Pioneering Gastroenterology Solutions

Medtronic (U.S.) is a key player in the gastroenterology market, providing cutting-edge products to diagnose and treat gastrointestinal conditions. Notable innovations include the GI Genius Intelligent Endoscopy Module, launched in 2021, which uses AI to enhance colorectal polyp detection during colonoscopies. Medtronic also offers the PillCam capsule endoscopy, a minimally invasive tool that captures comprehensive images of the digestive tract, aiding in the detection of diseases such as Crohn's disease and gastrointestinal bleeding. With continuous investment in R&D and advanced technologies, Medtronic remains a leader in improving patient care and procedural efficiency in the gastroenterology sector.

Olympus Corporation: Leader in Endoscopic Technologies

Olympus Corporation (Japan) is a major provider of innovative endoscopic technologies in the gastroenterology market. The EVIS X1 endoscopy system, featuring advanced imaging technologies like Texture and Color Enhancement Imaging (TXI), Red Dichromatic Imaging (RDI), and Narrow Band Imaging (NBI), enhances visualization for early detection of GI conditions. Olympus also offers a range of therapeutic devices, including the DualKnife J for precise tissue resection and the Endocuff Vision device, which improves mucosal exposure during colonoscopy. With a strong commitment to innovation, Olympus continues to lead in providing advanced tools for diagnostic and therapeutic gastroenterological procedures.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20605595

Device Segment: Endoscopy Leads the Gastrointestinal Products Market

The Gastroenterology Market is segmented by device type into Endoscopy, Ablation systems, Motility testing, Biopsy devices, Stenting devices, pH monitoring devices, and other devices. The endoscopy segment is further divided into Colonoscopy, Sigmoidoscopes, and other endoscopy devices. In the forecast period, the endoscopy segment is expected to account for the largest market share. Technological advancements, such as high-definition imaging, narrow-band imaging (NBI), and robotic-assisted and capsule endoscopy, have made endoscopic procedures more sophisticated and minimally invasive. These procedures offer reduced patient discomfort, faster recovery times, and fewer complications compared to traditional surgical methods, driving their adoption.

Disease Segment: GERD Drives Growth in Gastrointestinal Products Market

The Gastrointestinal Products Market is classified by disease into Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Gastrointestinal Cancers, and other diseases. During the forecast period, the GERD segment is projected to experience the largest growth. The increasing prevalence of GERD is driven by factors such as the consumption of processed and high-fat foods, obesity, and aging populations. Obesity places additional pressure on the stomach, increasing reflux episodes, while smoking and excessive alcohol use weaken the lower esophageal sphincter (LES), allowing acid reflux. As the aging population grows, the demand for GERD diagnostics and treatments continues to rise.

Regional Insights: North America Dominates the Gastroenterology Market

The Gastrointestinal Products Market is segmented by geography into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold the largest share of the market during the forecast period. The region's well-established healthcare infrastructure, including advanced hospital systems and healthcare facilities, combined with an aging population, sedentary lifestyles, and poor dietary habits, contributes to the rising prevalence of gastrointestinal disorders. This drives the demand for gastroenterology products across the region.

For more information, inquire now! Inquire Now

Related Reports:

Medical Equipment Maintenance Market

Ablation Technology Market

Diagnostic Imaging Market

Endoscopy Equipment Market

Laparoscopic Instruments Market

Get access to the latest updates on Gastrointestinal Products Companies and Gastrointestinal Products Market Share

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/gastrointestinal-products-market-worth-19-7-billion-in-2029-driven-by-increasing-tech-innovations--marketsandmarkets-302233911.html

© 2024 PR Newswire
Besser als NVIDIA! 3 KI- Favoriten mit riesigem Potenzial

Erleben Sie die KI-Revolution und sichern Sie sich gigantische Gewinne!

Nutzen Sie die einmalige Gelegenheit, die Ihnen die Künstliche Intelligenz bietet! Unser exklusiver Aktienreport enthüllt drei unglaublich aussichtsreiche KI-Aktien, die von der bahnbrechenden Entwicklung in diesem Sektor massiv profitieren können.

Warum sollten Sie dabei sein?

Weil eine Investition in KI-Unternehmen nicht nur Stabilität bringt, sondern auch das Potenzial hat, Ihr Depot explosionsartig wachsen zu lassen. Die letzten Jahre haben bewiesen: Wer auf KI setzt, kann außergewöhnliche Gewinne einfahren. Jetzt, nach einer kurzen Konsolidierungsphase, öffnen sich wieder sensationelle Einstiegsmöglichkeiten.

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche KI-Aktien das größte Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen die besten Investments im KI-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.